1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Enteral Nutrition Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Enteral Nutrition Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Increasing Prevalence of Gastrointestinal Diseases
5.2 Market Opportunities
- 5.2.1 Strategic Initiatives by Key Market Players
5.3 Future Trends
- 5.3.1 Standardized Formulations and Plant-Based Nutrition Products
5.4 Impact of Drivers and Restraints
6. Europe Enteral Nutrition Market Regional Analysis
6.1 Europe Enteral Nutrition Market Overview
6.2 Europe Enteral Nutrition Market Revenue 2021-2031 (US$ Million)
6.3 Europe Enteral Nutrition Market Forecast Analysis
7. Europe Enteral Nutrition Market Analysis – by Product Type
7.1 Nasogastric
- 7.1.1 Overview
- 7.1.2 Nasogastric: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Nasoenteral
- 7.2.1 Overview
- 7.2.2 Nasoenteral: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Sipping
- 7.3.1 Overview
- 7.3.2 Sipping: Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Enteral Nutrition Market – Europe Analysis
8.1 Europe
- 8.1.1 Europe Enteral Nutrition Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 8.1.1.1 Europe Enteral Nutrition Market – Revenue and
Forecast Analysis – by Country
- 8.1.1.1 UK:
Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.1.1 UK: Europe Enteral Nutrition Market Breakdown, by Product Type
- 8.1.1.2 Germany:
Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.2.1 Germany: Europe Enteral Nutrition Market Breakdown, by Product Type
- 8.1.1.3 France:
Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.3.1 France: Europe Enteral Nutrition Market Breakdown, by Product Type
- 8.1.1.4 Russia:
Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.4.1 Russia: Europe Enteral Nutrition Market Breakdown, by Product Type
- 8.1.1.5 Italy:
Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.5.1 Italy: Europe Enteral Nutrition Market Breakdown, by Product Type
- 8.1.1.6 Rest of Europe:
Europe Enteral Nutrition Market – Revenue and Forecast to 2031 (US$ Million)
- 8.1.1.6.1 Rest of Europe: Europe Enteral Nutrition Market Breakdown, by Product Type
9. Competitive Landscape
9.1 Heat Map Analysis
9.2 Company Positioning and Concentration
10. Europe Enteral Nutrition Market Industry Landscape
10.1 Overview
10.2 Mergers and Acquisitions
10.3 Agreements, Collaborations, and Joint Ventures
10.4 New Product Launches
10.5 Expansions and Other Strategic Developments
11. Company Profiles
11.1 Nestlé
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Danone S.A.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Abbott Laboratories
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 FrieslandCampina
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Fresenius SE and Co. KGaA
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 B. Braun SE
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Dr. Schär AG
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Arla Food
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Reckitt Benckiser
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Perrigo Company PLC
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 Fonterra Co-operative Group Limited
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
11.12 Kate Farms
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
11.13 Nutritional Medicinals, LLC
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
12. Appendix
12.1 About Business Market Insights